Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat

Journal of Hepatology

Volumn 26, Issue 1, 1997, Pages 158-166

  Zimmermann, Heinz ^a   Fellay, Maurice ^a   Zimmermann, Arthur ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

biliary cirrhosis; hepatic stellate cells; Ito cells; portal hypertension; reversibility

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ITO CELL; LIVER CIRRHOSIS; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL;

EID: 0031027703     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80022-0     Document Type: Article

References (64)

1. Desmet VJ. Cholestasis; extrahepatic obstruction and secondary biliary cirrhosis. Mac Sween RNM, Anthony PP, Scheuer PJ. 4th edn. Pathology of the Liver. 1979;272-305 Churchill Livingstone, Edinburgh.
2. Adson MA, Wychulis AR. Portal hypertension in secondary biliary cirrhosis. Arch Surg. 96:1968;604-612.
3. Way LW, Bernhoft RA, Thomas MJ. Biliary stricture. Surg Clin North Am. 61:1981;963-972.
4. Kontouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Path. 65:1984;305-311.
5. Gross JB, Reichen J, Zeltner TB, Zimmermann A. The evolution of changes in quantitative liver function tests in the rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology. 7:1987;457-463.
6. Clément B, Loréal O, Levavasseur F, Guillouzo A. New challenges in hepatic fibrosis. J Hepatol. 18:1993;1-4.
7. Himeno H, Saibara T, Hara H. Recent studies on Ito cells with molecular biology. Nippon Rinsho. 51:1993;472-481.
8. Gressner AM, Krull N, Bachem MG. Regulation of proteoglycan expression in fibrotic liver and cultured fat-storing cells. Pathol Res Pract. 190:1994;864-882.
9. Gressner AM, Lotfi S, Gressner G, Lahme B. Identification and partial characterization of a hepatocyte-derived factor promoting proliferation of cultured fat-storing cells (parasinusoidal lipocytes). Hepatology. 16:1992;1250-1266.
10. Henriksen JH, Lassen NA. Pressure profile in liver sinusoids. A model of localization of sinusoidal resistance in the normal and cirrhotic liver. Liver. 8:1988;88-94.
11. Zimmermann H, Reichen J, Zimmermann A, Sägesser H, Thenisch B, Höflin R. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. Effect of relief of biliary obstruction on microsomal lipids, portal pressure and hepatic structure. Gastroenterology. 103:1992;579-589.
12. Aronson DC, Chamuleau RAFM, Frederiks WM, Gooszen HG, Heijmans HSA, James J. Reversibility of cholestatic changes following experimental common bile duct obstruction. Fact or fantasy? J Hepatol. 18:1993;85-95.
13. Cruz-Orive LM, Weibel ER. Sampling design for stereology. J Microsc. 122:1981;235-257.
14. Schmitt Graff A, Kruger S, Bochard F, Gabbiani G, Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol. 138:1991;1233-1242.
15. Johnson SJ, Hines JE, Burt AD. Immunolocalization of proliferating perisinusoidal cells in rat liver. Histochem J. 24:1992;67-72.
16. Yokoi Y, Namihisa T, Matsuzaki K, Miyasaki A, Yamaguchi Y. Distribution of Ito cells in experimental hepatic fibrosis. Liver. 8:1988;48-52.
17. Ballardini G, Fallani M, Biagini G, Bianchi FB. Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol. 56:1988;45-49.
18. Mancini R, Jezequel AM, Benedetti A, Paolucci F, Trozzi L, Orlandi F. Quantitative analysis of proliferating sinusoidal cells in dimethylnitrosamine-induced cirrhosis. An immunohistochemical study. J Hepatol. 15:1992;361-366.
19. Weibel ER. Stereological Methods. 1979;Academic Press, London.
20. Geerts A, Bouwens L, Wisse E. Ultrastructure and function of hepatic fat-storing and pit cells. J Electron Microsc Tech. 14:1990;247.
21. Glantz SA. 3rd edn. Primer of Biostatistics. 1992;McGraw-Hill, New York.
22. Gall JA, Bhathal PS. A quantitative analysis of the liver following ligation of the common bile duct. Liver. 10:1990;116-125.
23. Ramadori G. Pathogenesis of liver fibrosis. Synthesis of collagen and non-collagen proteins in cell culture and in vivo. Z Gastroenterol. 30:1992;17-20. Suppl 1.
24. Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. Cytol Pathol. 24:1992;193-203.
25. De Leuw AM, McCarthy SP, Geerts A, Knook DL. Purified rat liver fat storing cells in culture divide and contain collagen. Hepatology. 4:1984;392-403.
26. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B Cell Pathol. 61:1991;147-158.
27. Jezequel AM, Mancini R, Rinaldesi ML, Ballardini G, Fallani M, Bianchi F, Orlandi F. Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol. 8:1989;42-52.
28. Lissoos TW, Davis BH. Pathogenesis of hepatic fibrosis and the role of cytokines. J Clin Gastroenterol. 15:1992;63-67.
29. Bissell DM, Friedman SL, Maher JJ, Roll FJ. Connective tissue biology and hepatic fibrosis: Report of a conference. Hepatology. 11:1990;488-498.
30. Friedman SL, Roll JF, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA. 82:1985;8681-8685.
31. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-beta1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 85:1990;1833-1843.
32. Ramadori G, Knittel T, Odenthal M, Schwogler S, Neubauer K, Meyer zum Buschenfelde KH. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology. 103:1992;1313-1321.
33. Knittel T, Schuppan D, Meyer zum Buschenfelde KH, Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro (see comments). Gastroenterology. 102:1992;1724-1735.
34. Abdel Aziz G, Rescan PY, Clement B, Lebeau G, Rissel M, Grimaud JA, Campion JP, Guillouzo A. Cellular sources of matrix proteins in experimentally induced cholestatic rat liver. J Pathol. 164:1991;167-174.
35. Geerts A, Lazou JM, De Bleser P, Wisse E. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology. 13:1991;1193-1202.
36. Johnson SJ, Hines JE, Burt AD. Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol. 166:1992;351-358.
37. Gressner AM. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules. Z Gastroenterol. 30:1992;5-16. Suppl 1.
38. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 85:1990;1833-1843.
39. Armendariz Borunda J, Katayama K, Seyer JM. Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells. J Biol Chem. 267:1992;14316-14321.
40. Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol Res Pract. 190:1994;825-833.
41. 4- or vitamin A-treated rats. Dig Dis Sci. 32:1987;1281.
42. Hines JE, Johnson SJ, Burt AD. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol. 142:1993;511-518.
43. Abdel Aziz G, Lebeau G, Rescan PY, Clément B, Rissel M, Deugnier Y, Campion JP, Guizillo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in the rat. Am J Pathol. 137:1990;1333-1342.
44. Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, Seiko M, Ooshima A, Watanabe A. Increased expression of matrix metalloproteinase-ii in experimental liver fibrosis in rats. Hepatology. 21:1995;787-795.
45. Yamamoto H, Murawaki Y, Kawasaki H. Hepatic collagen synthesis and degradation during liver regeneration after partial hepatectomy. Hepatology. 21:1995;155-161.
46. Reichen J. Etiology and pathophysiology of portal hypertension. Z Gastroenterol. 26:1988;3-7. Suppl 2.
47. Shibayama Y, Nakata K. Relation of sinusoidal stenoses following hepatocyte swelling to hepatic vascular resistance in experimental liver cirrhosis. Liver. 9:1989;36-42.
48. Shibayama Y, Nakata K. The role of sinusoidal stenoses in portal hypertension of liver cirrhosis. J Hepatol. 8:1989;60-66.
49. Shibayama Y. On the pathogenesis of portal hypertension in cirrhosis of the liver. Liver. 8:1988;95-99.
50. Lee SS, Hadengue A, Girod C, Braillon A, Lebrec D. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat. Gastroenterology. 93:1987;157-161.
51. Sherman IA, Pappas SC, Fisher MM. Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis. Am J Physiol. 258:1990;H460-H465.
52. Kawada N, Tran Thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem. 213:1993;815-823.
53. Schmitt Graff A, Chakroun G, Gabbiani G. Modulation of perisinusoidal cell cytoskeletal features during experimental hepatic fibrosis. Virchows Arch A Pathol Anat Histopathol. 422:1993;99-107.
54. Rubin JR, Marmen C, Rhodes RS. Management of failed prosthetic grafts at the time of major lower extremity amputation. J Vasc Surg. 7:1988;673-676.
55. Kurzen P, Zimmermann H, Marti U, Reichen J. Decreased endothelial nitric oxide synthase (eNOS) expression in hepatocytes of secondary biliary cirrhosis in the rat. J Hepatol. 23:1995;116.
56. Rockey DC, Chung JJ. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest. 95:1995;1199-1206.
57. Gerbes AL, Gülberg V, Sägesser H, Reichen J. Circulating endothelin (ET)-1 and ET-3 in experimental cirrhosis: relation to renal sodium handling but not to renal extraction of ET nor to liver function. Hepatology. 22:1995;164A.
58. Tsai YT, Lin HC, Yang MCM, Lee FY, Hou MC, Chen LS, Lee SD. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. J Hepatol. 23:1995;681-688.
59. Hartleb M, Moreau R, Cailmail S, Gaudin C, Lebrec D. Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis. Gastroenterology. 107:1994;1201-1203.
60. Zhang JX, Pegoli W Jr., Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol (United States). 266:1994;G624-G632.
61. Kawada N, Tran-Thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem. 213:1993;815-823.
62. Richard V, Hogie M, Clozel M, Loffler BM, Thuillez C. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 91:1995;77.
63. Robert P, Champigneulle B, Kreher I, Gueant JL, Foliguet B, Dollet JM, Bigard MA, Gaucher P. Evaluation of fibrosis in the Disse space in noncirrhotic alcoholic liver disease. Alcohol Clin Exp Res. 13:1989;176-180.
64. van Leeuwen DJ, Howe SC, Scheuer PJ, Sherlock S. Portal hypertension in chronic hepatitis: relationship to morphological changes. Gut. 31:1990;339-343.